Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07502950

ROTEM Interpretation AI vs Experts

This prospective multicenter observational study aims to evaluate the agreement between artificial intelligence (AI)-based interpretation and expert interpretation of rotational thromboelastometry (ROTEM) findings in clinically relevant settings. ROTEM is widely used to guide hemostatic therapy in perioperative and critically ill patients, but its interpretation is complex and subject to interobserver variability.

The primary objective is to determine whether AI-based interpretation achieves agreement comparable to variability between expert clinicians. Secondary objectives include comparison of interpretation time, assessment of consistency of AI outputs, and evaluation of potential differences in clinical decision-making.

ROTEM datasets will be independently assessed by multiple expert anesthesiologists and by an AI-based model using standardized input. Agreement between methods and variability of interpretation will be analyzed.

The study aims to determine whether AI-assisted interpretation could serve as a reliable decision-support tool and reduce variability in ROTEM-guided clinical practice.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This prospective multicenter observational study is designed to evaluate the agreement between artificial intelligence (AI)-based interpretation and expert interpretation of rotational thromboelastometry (ROTEM) findings, with a focus on clinical decision-making in critically ill patients.

ROTEM is a point-of-care viscoelastic method providing real-time information on coagulation, including clot formation, strength, and fibrinolysis. It is widely used to guide targeted hemostatic therapy in trauma, major surgery, and critical care. However, interpretation of ROTEM findings is complex and requires clinical expertise. Interobserver variability among clinicians may lead to inconsistent therapeutic decisions. Although algorithm-based approaches have been introduced, their implementation remains variable.

Artificial intelligence (AI) has the potential to standardize interpretation by integrating multiple ROTEM parameters and generating consistent recommendations. Previous studies have shown that machine learning models can predict clinical outcomes or transfusion requirements based on viscoelastic data. However, evidence on agreement between AI-based interpretation and expert interpretation, particularly in real-world clinical decision-making, remains limited.

The primary objective of this study is to determine whether AI-based interpretation achieves a level of agreement comparable to inter-expert variability in ROTEM interpretation. This study does not assume a single gold standard; instead, it evaluates agreement between methods, reflecting real-world clinical practice.

Secondary objectives include:

  • comparison of interpretation time between AI and expert clinicians,
  • assessment of consistency (intra-method variability) of AI compared to inter-expert variability,
  • evaluation of potential impact on clinical decision-making, including identification of coagulation abnormalities and proposed treatment strategies.

ROTEM measurements will be collected and presented in a standardized format, including graphical and numerical outputs. Each dataset will be independently evaluated by multiple expert anesthesiologists. The same datasets will be interpreted repeatedly by an AI-based large language model using a predefined standardized prompt, with multiple independent runs to assess intra-model variability.

For each ROTEM dataset, both experts and AI will assess:

  • presence of a coagulation disorder,
  • dominant underlying abnormality,
  • appropriate therapeutic intervention,
  • and recommended treatment dose.

Agreement between experts and AI, as well as inter-expert agreement, will be analyzed using appropriate statistical methods for categorical and continuous variables (e.g., kappa statistics and intraclass correlation coefficients). Time required for interpretation will also be recorded and compared.

This study is not designed to determine the absolute correctness of interpretation, but to quantify agreement and variability between human experts and AI. By identifying clinically relevant discrepancies, the study aims to evaluate whether AI-assisted interpretation may serve as a reliable decision-support tool and reduce variability in ROTEM-guided hemostatic management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients (age ≥18 years)

  • ROTEM analysis performed using a ROTEM Sigma device as part of routine clinical care
  • Availability of complete ROTEM output (graphical and numerical data)
  • ROTEM measurement obtained in a clinical context where assessment of coagulation status is indicated (e.g., perioperative setting, trauma, or critical illness)

Exclusion criteria

  • ROTEM measurements performed using the HEPTEM channel
  • Incomplete or missing ROTEM data preventing standardized evaluation
  • ROTEM measurements obtained under non-standardized or technically unreliable conditions

Treatment and study plan

Large Language Model (LLM) artificial intelligence assesment

Other

The thromboelastography record will be assessed by LLM based artificial intelligence.

Primary outcomes

  1. Agreement between AI-based and expert interpretation of ROTEM findings

    Time frame: Up to 24 hours after ROTEM measurement (time required for interpretation and data recording).

    Agreement between artificial intelligence (AI)-based interpretation and expert interpretation of ROTEM findings will be assessed and compared to inter-expert agreement. Agreement will be evaluated for predefined clinical decision outputs, including:

    • presence of coagulation disorder (yes/no),
    • identification of dominant coagulation abnormality (categorical),
    • selection of therapeutic intervention (categorical),
    • and recommended treatment dose (continuous).

    Agreement will be quantified using appropriate statistical methods for categorical and continuous data (e.g., Cohen's/Fleiss' kappa and intraclass correlation coefficients).

Secondary outcomes

  1. Interpretation time

    Time frame: Up to 24 hours after ROTEM measurement.

    Time required for interpretation of ROTEM findings by expert clinicians compared to AI-based interpretation. For experts, time will be measured from presentation of the ROTEM result to completion of responses. For AI, time will be measured from submission of the standardized query to completion of output generation.

  2. Consistency of interpretation (intra-method variability)

    Time frame: Up to 24 hours after ROTEM measurement

    Variability of AI-based interpretation across repeated independent runs will be assessed and compared with inter-expert variability. Consistency will be evaluated for all predefined outputs (diagnosis, treatment, dosing).

  3. Proportion of clinically discordant decisions

    Time frame: Up to 24 hours after ROTEM measurement

    Proportion of cases in which AI-based interpretation differs from expert interpretation in clinically relevant outputs, including:

    • disagreement in diagnosis of coagulation disorder,
    • disagreement in selected treatment strategy,
    • or clinically relevant difference in recommended dose.
  4. Inter-expert agreement

    Time frame: Up to 24 hours after ROTEM measurement

    Agreement between individual expert clinicians in interpretation of ROTEM findings will be evaluated to define baseline interobserver variability and provide a reference for comparison with AI-based interpretation.

Other outcomes

  1. Potential treatment change

    Time frame: Up to 24 hours after ROTEM measurement

    Proportion of disagreement between expert panel and LLM based AI that would lead to treatment change.

Sponsors and collaborators

Lead sponsor

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

Other

Registry information

Official study title

Artificial Intelligence Versus Expert Interpretation of ROTEM: A Prospective Study of Agreement and Clinical Decision-Making

Acronym: ROTEMAI

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 31, 2026
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.